Patent · US Expired

Immunoprotective influenza antigen and its use in vaccination

US7731972B1 · kind B1 · utility

8Cited by

5References

17Claims

0Family size

Assignee

VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW · BE

Inventors

Sabine Neirynck · Lokeren, BE
Willy Min Jou · Laarne, BE
Walter Fiers · Laarne, BE

Key dates

Filing date	Feb 4, 2000
Grant date	Jun 8, 2010
Priority date	—
Expiry date	Feb 4, 2020

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16122
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an influenza antigen, comprising a fusion product of at least (1) the extracellular part of a conserved influenza membrane protein (e.g., M2) or a functional equivalent thereof and (2) a presenting carrier. The presenting carrier may be a (poly)peptide or a non-peptidic structure such as glycans, peptide mimetics, and synthetic polymers. The invention further relates to methods of making and using the antigen, and to influenza vaccines comprising the antigen and optionally one or more excipients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.